Identifying birth defects in automated data sources in the Vaccine Safety Datalink

Pharmacoepidemiology and Drug Safety

Volumn 26, Issue 4, 2017, Pages 412-420

  Kharbanda, Elyse Olshen ^a   Vazquez Benitez, Gabriela ^a   Romitti, Paul A ^b   Naleway, Allison L ^c   Cheetham, T Craig ^d   Lipkind, Heather S ^e   Sivanandam, Shanthi ^f   Klein, Nicola P ^d   Lee, Grace M ^g   Jackson, Michael L ^h   Hambidge, Simon J ⁱ   Olsen, Avalow ^a   McCarthy, Natalie ^j   DeStefano, Frank ^j   Nordin, James D ^a  

^a HEALTHPARTNERS INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d KAISER PERMANENTE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

^h GROUP HEALTH RESEARCH INSTITUTE   (United States)

ⁱ DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^j CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

congenital anomalies; electronic health data; pharmacoepidemiology; prevalence; validity

Indexed keywords

VACCINE;

ADULT; ALGORITHM; ARTICLE; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DRUG SAFETY; ELECTRONIC HEALTH RECORD; EUROPEAN; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HUMAN; INFANT; LIVE BIRTH; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; VALIDATION STUDY; YOUNG ADULT; ADOLESCENT; CONGENITAL ABNORMALITIES; DRUG SURVEILLANCE PROGRAM; HEALTH SURVEY; MALE; MIDDLE AGED; PREGNANCY;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREGNANCY; PREVALENCE; UNITED STATES; VACCINES; YOUNG ADULT;

EID: 85007560874     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.4153     Document Type: Article

References (41)

1. Mitchell AA, Gilboa SM, Werler MM, et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol 2011; 205(1): 51 e51–58.
2. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004; 191(2): 398–407.
3. Groom HC, Henninger ML, Smith N, et al. Influenza vaccination during pregnancy: influenza seasons 2002-2012, Vaccine Safety Datalink. Am J Prev Med 2016; 50(4): 480–488.
4. Thorpe PG, Gilboa SM, Hernandez-Diaz S, et al. Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf 2013; 22(9): 1013–1018.
5. Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. American journal of medical genetics. Part C, Seminars in medical genetics 2011; 157C(3): 175–182.
6. Chamberlain AT, Seib K, Ault KA, et al. Factors associated with intention to receive influenza and tetanus, diphtheria, and acellular pertussis (Tdap) vaccines during pregnancy: a focus on vaccine hesitancy and perceptions of disease severity and vaccine safety. PLoS Curr 2015; 7. DOI: 10.1371/currents/outbreaks.d37b61bceebae5a7a06d40a301cfa819.
7. Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season. MMWR Morb Mortal Wkly Rep 2015; 64(30): 818–825.
8. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013; 62(7): 131–135.
9. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013. Vaccine 2016; 34(7): 968–973.
10. Petrosky E, Bocchini JA, Jr, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015; 64(11): 300–304.
11. MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW. Use of serogroup B meningococcal vaccines in adolescents and young adults: Recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep 2015; 64(41): 1171–1176.
12. Baggs J, Gee J, Lewis E, et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics 2011; 127(Suppl 1): S45–53.
13. Kharbanda EO, Vazquez-Benitez G, Lipkind H, et al. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites. Prev Med 2014; 67: 316–319.
14. Naleway AL, Kurosky S, Henninger ML, et al. Vaccinations given during pregnancy, 2002-2009: a descriptive study. Am J Prev Med 2014; 46(2): 150–157.
15. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA 2014; 312(18): 1897–1904.
16. Nordin JD, Kharbanda EO, Vazquez Benitez G, Lipkind H, Vellozzi C, Destefano F. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr 2014; 164(5): 1051–1057.
17. Nordin JD, Kharbanda EO, Vazquez-Benitez G, Lipkind H, Lee GM, Naleway AL. Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events. Vaccine 2014; 32(39): 4985–4992.
18. Sukumaran L, McCarthy NL, Kharbanda EO, et al. Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations. JAMA 2015; 314(15): 1581–1587.
19. Sukumaran L, McCarthy NL, Kharbanda EO, et al. Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy. Obstet Gynecol 2015; 126(5): 1069–1074.
20. Salemi JL, Tanner JP, Sampat D, et al. The accuracy of hospital discharge diagnosis codes for major birth defects: evaluation of a statewide registry with passive case ascertainment. J Public Health Manag Pract 2016; 22(3): E9–E19.
21. Frohnert BK, Lussky RC, Alms MA, Mendelsohn NJ, Symonik DM, Falken MC. Validity of hospital discharge data for identifying infants with cardiac defects. Journal of perinatology: official journal of the California Perinatal Association 2005; 25(11): 737–742.
22. Cooper WO, Hernandez-Diaz S, Gideon P, et al. Positive predictive value of computerized records for major congenital malformations. Pharmacoepidemiol Drug Saf 2008; 17(5): 455–460.
23. Calle EE, Khoury MJ. Completeness of the discharge diagnoses as a measure of birth defects recorded in the hospital birth record. Am J Epidemiol 1991; 134(1): 69–77.
24. Hexter AC, Harris JA, Roeper P, Croen LA, Krueger P, Gant D. Evaluation of the hospital discharge diagnoses index and the birth certificate as sources of information on birth defects. Public Health Rep 1990; 105(3): 296–307.
25. Boulet SL, Shin M, Kirby RS, Goodman D, Correa A. Sensitivity of birth certificate reports of birth defects in Atlanta, 1995-2005: effects of maternal, infant, and hospital characteristics. Public Health Rep 2011; 126(2): 186–194.
26. Correa-Villasenor A, Cragan J, Kucik J, O'Leary L, Siffel C, Williams L. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res A Clin Mol Teratol 2003; 67(9): 617–624.
27. Reefhuis J, Gilboa SM, Anderka M, et al. The National Birth Defects Prevention Study: a review of the methods. Birth Defects Res A Clin Mol Teratol 2015; 103(8): 656–669.
28. Dolk H. EUROCAT: 25 years of European surveillance of congenital anomalies. Arch Dis Child Fetal Neonatal Ed 2005; 90(5): F355–358.
29. DeSilva M, Munoz FM, McMillan M, et al. Congenital anomalies: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2016; 34(49): 6015–6026.
30. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2003; 67(3): 193–201.
31. Johnson CY, Honein MA, Dana Flanders W, Howards PP, Oakley GP, Jr, Rasmussen SA. Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature. Birth Defects Res A Clin Mol Teratol 2012; 94(11): 857–863.
32. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42(2): 377–381.
33. Feldkamp ML, Botto LD, Amar E, et al. Cloacal exstrophy: an epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet C Semin Med Genet 2011; 157C(4): 333–343.
34. Kucik JE, Alverson CJ, Gilboa SM, Correa A. Racial/ethnic variations in the prevalence of selected major birth defects, metropolitan Atlanta, 1994-2005. Public Health Rep 2012; 127(1): 52–61.
35. Centers for Disease C, Prevention. Update on overall prevalence of major birth defects—Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep 2008; 57(1): 1–5.
36. Andrade SE, Scott PE, Davis RL, et al. Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf 2013; 22(1): 7–15.
37. Division of Birth Defects and Developmental Disabilities, NCBDDD, Centers for Disease Control and Prevention. Facts about microcephaly. http://www.cdc.gov/ncbddd/birthdefects/microcephaly.html. Accessed May 20, 2016.
38. Society for Maternal-Fetal Medicine Publications C. Ultrasound screening for fetal microcephaly following Zika virus exposure. Am J Obstet Gynecol 2016; 214(6): B2–4.
39. Garne E, Loane M, Wellesley D, Barisic I, Eurocat WG. Congenital hydronephrosis: prenatal diagnosis and epidemiology in Europe. J Pediatr Urol 2009; 5(1): 47–52.
40. McMillan M, Porritt K, Kralik D, Costi L, Marshall H. Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine 2015; 33(18): 2108–2117.
41. Sukumaran L. From the Vaccine Safety Datalink (VSD): maternal Tdap vaccination and structural birth defects in offspring. Paper presented at: Advisory Committee on Immunization Practices (ACIP) 2016; Atlanta, GA.